e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary alveolar microlithiasis: genetic disorder and concomitant altered calcium metabolism
Y. Pascual-González (L'Hospitalet de Llobregat, Spain), E. Cuevas (L'Hospitalet de Llobregat, Spain), P. Luburich (L'Hospitalet de Llobregat, Spain), V. Vicens-Zygmunt (L'Hospitalet de Llobregat, Spain)
Source:
Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Session:
Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Session type:
E-poster session
Number:
3490
Disease area:
Interstitial lung diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Pascual-González (L'Hospitalet de Llobregat, Spain), E. Cuevas (L'Hospitalet de Llobregat, Spain), P. Luburich (L'Hospitalet de Llobregat, Spain), V. Vicens-Zygmunt (L'Hospitalet de Llobregat, Spain). Pulmonary alveolar microlithiasis: genetic disorder and concomitant altered calcium metabolism. 3490
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult
Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019
Year: 2020
Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency
Source: Eur Respir J 2016; 48: 1510-1514
Year: 2016
New mutation associated to the pulmonary alveolar microlithiasis
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Pulmonary alveolar microlithiasis: two case reports and review of the literature
Source: Eur Respir Rev 2012 21:249-256
Year: 2012
Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 152-160
Year: 2012
Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Contribution of epithelial-to-mesenchymal transition to phenotypic changes in idiopathic interstitial pneumonias
Source: International Congress 2015 – New insights into IIPs
Year: 2015
The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Peculiarities of pulmonary alveolar proteinosis (PAP) due to exogenous factors
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020
Pulmonary emphysema and idiopathic pulmonary fibrosis: Is the pattern of exercise-induced oxygen desaturation same or different?
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010
Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases?
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Dysregulation of iron homeostasis in Eisenmenger syndrome; comparison to idiopathic pulmonary arterial hypertension and healthy controls
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Pulmonary alveolar microlithiasis
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019
Pulmonary alveolar microlithiasis
Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020
Year: 2020
Iron deficiency is common in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 1386-1391
Year: 2011
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Nutritional intervention in cystic fibrosis
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=153
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept